Is Day One Biopharmaceuticals, Inc. (DAWN) a Buy, Sell, or Hold?
Day One Biopharmaceuticals, Inc.
NASDAQ:DAWN
$21.53 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 4.01M
- Market Capitalization
- $2.22B
- P/E Ratio
- -20.70
- Dividend Yield
- 0.00%
- Price Target
- $21.50
- Year High
- $21.53
- Year Low
- $5.64
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $8.02
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
100
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
152
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 11.34M
DAWN Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
DAWN Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| AI Day1 LLC | 10 percent owner | 2026-04-23 | U-Tender | 21.5 | 2026-04-27 |
| AI Day1 LLC | 10 percent owner | 2026-04-23 | D-Return | 0.0001 | 2026-04-27 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-04-23 | D-Return | 0.0001 | 2026-04-23 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-04-23 | D-Return | 11.16 | 2026-04-23 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-04-23 | D-Return | 0.0001 | 2026-04-23 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-04-23 | D-Return | 6.64 | 2026-04-23 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-04-23 | D-Return | 11.16 | 2026-04-23 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| York Charles N II | officer: COO and CFO | 2026-04-23 | D-Return | 0.0001 | 2026-04-23 |
| York Charles N II | officer: COO and CFO | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| York Charles N II | officer: COO and CFO | 2026-04-23 | D-Return | 11.16 | 2026-04-23 |
| York Charles N II | officer: COO and CFO | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-04-23 | D-Return | 0.0001 | 2026-04-23 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-04-23 | D-Return | 11.16 | 2026-04-23 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Holles Natalie C. | director | 2026-04-23 | D-Return | 0.0001 | 2026-04-23 |
| Holles Natalie C. | director | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Holles Natalie C. | director | 2026-04-23 | D-Return | 7.01 | 2026-04-23 |
| Holles Natalie C. | director | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Ramasastry Saira | director | 2026-04-23 | D-Return | 0.0001 | 2026-04-23 |
| Ramasastry Saira | director | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Ramasastry Saira | director | 2026-04-23 | D-Return | 7.01 | 2026-04-23 |
| Ramasastry Saira | director | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Josey John A. | director | 2026-04-23 | D-Return | 0.0001 | 2026-04-23 |
| Josey John A. | director | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Josey John A. | director | 2026-04-23 | D-Return | 7.01 | 2026-04-23 |
| Josey John A. | director | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Garland J. Scott | director | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Garland J. Scott | director | 2026-04-23 | D-Return | 7.01 | 2026-04-23 |
| Garland J. Scott | director | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Dable Habib J | director | 2026-04-23 | D-Return | 7.01 | 2026-04-23 |
| Dable Habib J | director | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Dable Habib J | director | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Grossman William | director | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Grossman William | director | 2026-04-23 | D-Return | 7.01 | 2026-04-23 |
| Grossman William | director | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Nicholson Garry A | director | 2026-04-23 | D-Return | 7.01 | 2026-04-23 |
| Nicholson Garry A | director | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Nicholson Garry A | director | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-04-23 | D-Return | 0.0001 | 2026-04-23 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-04-23 | D-Return | 8.99 | 2026-04-23 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-04-23 | D-Return | 11.16 | 2026-04-23 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-04-23 | D-Return | 0 | 2026-04-23 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-17 | S-Sale | 11.6009 | 2026-02-18 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-17 | S-Sale | 11.6009 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-17 | S-Sale | 11.6009 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-17 | S-Sale | 11.6009 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-02-15 | M-Exempt | 0 | 2026-02-18 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-02-17 | S-Sale | 11.6009 | 2026-02-18 |
| York Charles N II | officer: COO and CFO | 2026-01-30 | A-Award | 11.16 | 2026-01-30 |
| York Charles N II | officer: COO and CFO | 2026-01-30 | A-Award | 0 | 2026-01-30 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-01-30 | A-Award | 11.16 | 2026-01-30 |
| VASCONCELLES MICHAEL | officer: Head of Research and Dev. | 2026-01-30 | A-Award | 0 | 2026-01-30 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-01-30 | A-Award | 11.16 | 2026-01-30 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2026-01-30 | A-Award | 0 | 2026-01-30 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-01-30 | A-Award | 11.16 | 2026-01-30 |
| Merendino Lauren | officer: Chief Commercial Officer | 2026-01-30 | A-Award | 0 | 2026-01-30 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-01-30 | A-Award | 11.16 | 2026-01-30 |
| Dubow Adam | officer: Gen Counsel & Secretary | 2026-01-30 | A-Award | 0 | 2026-01-30 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2025-11-25 | G-Gift | 0 | 2025-11-26 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2025-11-25 | G-Gift | 0 | 2025-11-26 |
| Bender Jeremy | director, officer: CHIEF EXECUTIVE OFFICER | 2025-11-25 | G-Gift | 0 | 2025-11-26 |